Wednesday, 21 July 2021

Nucleic Acid Isolation and Purification Market Size Share Trends Forecast 2026

 

Nucleic Acid Isolation and Purification Market, by Product Type (DNA & RNA Extraction and Purification Kits, Reagents, and Instruments), by Method (Column-based Isolation and Purification, Reagent-based Isolation and Purification, Magnetic Bead-based Isolation Purification, and Others), by Type (DNA Isolation and Purification and RNA Isolation and Purification), by Application (Diagnostics, Precision Medicine, Drug Discovery and Development, and Others), by End User (Pharmaceutical and Biotech Companies, Hospitals and Diagnostics Laboratories, Research Centers, and Contract Research Organizations ), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

High quality DNA and RNA are important for a wide variety of research and clinical applications. Purification or isolation of nucleic acids is the first step in most molecular biological studies and in all recombinant DNA techniques. The extraction of nucleic acids from biological material requires cell lysis, inactivation of cellular nucleases, and separation of the desired nucleic acid from cellular debris. Methods for purifying nucleic acids from cell extracts are often combinations of extraction/precipitation, chromatography, centrifugation, electrophoresis, and affinity separation. Pure nucleic acid has applications in emerging fields such as genetic engineering, molecular diagnosis, forensics, and research related to life sciences.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2420

Nucleic Acid Isolation and Purification Market Drivers

Increasing demand for nucleic acid test that is required for pipeline studies of genetic engineering and molecular diagnostics is the key driver for nucleic acid isolation and purification market growth. For Instance, in September 2012, GlaxoSmithKline initiated Phase 1 clinical study to evaluate the effects of chemotherapy and adoptive immunotherapy with T cells engineered to recognize NY-ESO-1 peptide in patients with unresectable, metastatic or recurrent synovial sarcoma. T immune cells are genetically engineered to express tumor-specific T cell receptor (TCR) genes and thereby kill cancer cells. The study is expected to complete by May 2020.

However, low adoption of automated nucleic acid isolation and purification procedures in emerging economies is a key factor restraining the global nucleic acid isolation and purification market growth.

Nucleic Acid Isolation and Purification Market- Regional Analysis

On the basis of region, the global nucleic acid isolation and purification market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing merger and acquisition activities in North America are expected to drive the nucleic acid isolation and purification market size. For Instance, in May 2018, Agilent Technologies Inc. acquired Lasergen, Inc. in a US$ 105 million deal. The collaboration has been done to develop next-generation sequencing workflow solutions for clinical applications.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/nucleic-acid-isolation-and-purification-market-2420

Furthermore, key players in Europe are focused on adopting acquisition strategies in order to enhance their market share. This in turn is expected to boost growth of the nucleic acid isolation and purification market in the region. For Instance, in February 2017, Qiagen Inc. acquired OmicSoft Corp. OmicSoft is recognized for its suite of software solutions that enable researchers to analyze and visualize their own datasets and compare them to massive volumes of publicly available ‘omics’ datasets. This acquisition aims at adding feature to the management, analysis, and sharing of both primary data and analyzed results, while also expanding the range of Qiagen’s translational and clinical applications.

Key players operating in the nucleic acid isolation and purification market include QIAGEN Inc., Thermo Fisher Scientific., F. Hoffmann-La Roche Ltd, Merck KGaA,, Agilent Technologies Inc., Illumina, Inc., Takara Bio Inc., Promega Corporation, General Electric Company, Danaher Corporation, New England Biolabs, and Bio-Rad Laboratories.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2420

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737


No comments:

Post a Comment